Recent Finacing
Recent Raise
Activiomics develops proprietary technologies for identifying drug biomarkers and profiling drug candidates, partnering with pharmaceutical and biotech companies on bespoke oncology and inflammation biomarker programs.
Focus Areas
Recent Investors
Total Raised
Funding round
Investors
